Caffeine in Food and
Dietary Supplements
Examining Safety
WORKSHOP SUMMARY
Leslie Pray, Ann L. Yaktine, and Diana Pankevich, Rapporteurs
Planning Committee for a Workshop on Potential Health Hazards
Associated with Consumption of Caffeine
in Food and Dietary Supplements
Food and Nutrition Board
Board on Health Sciences Policy
INSTITUTE OF MEDICINE
OF THE NATIONAL ACADEMIES
THE NATIONAL ACADEMIES PRESS
Washington, D.C.
THE NATIONAL ACADEMIES PRESS • 500 Fifth Street, NW • Washington, DC 20001
NOTICE: The workshop that is the subject of this workshop summary was approved by the Governing Board of the National Research Council, whose members are drawn from the councils of the National Academy of Sciences, the National Academy of Engineering, and the Institute of Medicine.
This activity was supported by Contract/Grant No. HHSF223200810020I between the National Academy of Sciences and the Department of Health and Human Services, Food and Drug Administration. The views presented in this publication do not necessarily reflect the views of the organizations or agencies that provided support for the activity.
International Standard Book Number-13: 978-0-309-29749-3
International Standard Book Number-10: 0-309-29749-4
Additional copies of this workshop summary are available for sale from the National Academies Press, 500 Fifth Street, NW, Keck 360, Washington, DC 20001; (800) 624-6242 or (202) 334-3313; http://www.nap.edu.
For more information about the Institute of Medicine, visit the IOM home page at www.iom.edu.
Copyright 2014 by the National Academy of Sciences. All rights reserved.
Printed in the United States of America
The serpent has been a symbol of long life, healing, and knowledge among almost all cultures and religions since the beginning of recorded history. The serpent adopted as a logotype by the Institute of Medicine is a relief carving from ancient Greece, now held by the Staatliche Museen in Berlin.
Suggested citation: IOM (Institute of Medicine). 2014. Caffeine in food and dietary supplements: Examining safety: Workshop summary. Washington, DC: The National Academies Press.
THE NATIONAL ACADEMIES
Advisers to the Nation on Science, Engineering, and Medicine
The National Academy of Sciences is a private, nonprofit, self-perpetuating society of distinguished scholars engaged in scientific and engineering research, dedicated to the furtherance of science and technology and to their use for the general welfare. Upon the authority of the charter granted to it by the Congress in 1863, the Academy has a mandate that requires it to advise the federal government on scientific and technical matters. Dr. Ralph J. Cicerone is president of the National Academy of Sciences.
The National Academy of Engineering was established in 1964, under the charter of the National Academy of Sciences, as a parallel organization of outstanding engineers. It is autonomous in its administration and in the selection of its members, sharing with the National Academy of Sciences the responsibility for advising the federal government. The National Academy of Engineering also sponsors engineering programs aimed at meeting national needs, encourages education and research, and recognizes the superior achievements of engineers. Dr. C. D. Mote, Jr., is president of the National Academy of Engineering.
The Institute of Medicine was established in 1970 by the National Academy of Sciences to secure the services of eminent members of appropriate professions in the examination of policy matters pertaining to the health of the public. The Institute acts under the responsibility given to the National Academy of Sciences by its congressional charter to be an adviser to the federal government and, upon its own initiative, to identify issues of medical care, research, and education. Dr. Harvey V. Fineberg is president of the Institute of Medicine.
The National Research Council was organized by the National Academy of Sciences in 1916 to associate the broad community of science and technology with the Academy’s purposes of furthering knowledge and advising the federal government. Functioning in accordance with general policies determined by the Academy, the Council has become the principal operating agency of both the National Academy of Sciences and the National Academy of Engineering in providing services to the government, the public, and the scientific and engineering communities. The Council is administered jointly by both Academies and the Institute of Medicine. Dr. Ralph J. Cicerone and Dr. C. D. Mote, Jr., are chair and vice chair, respectively, of the National Research Council.
PLANNING COMMITTEE FOR A WORKSHOP ON POTENTIAL HEALTH HAZARDS ASSOCIATED WITH CONSUMPTION OF CAFFEINE IN FOOD AND DIETARY SUPPLEMENTS1
LYNN R. GOLDMAN (Chair), Dean, School of Public Health and Health Sciences George Washington University, Washington, DC
JAMES R. COUGHLIN, President, Coughlin & Associates, San Diego, CA
STEPHEN R. DANIELS, Professor and Chair, Department of Pediatrics, University of Colorado, Aurora
THOMAS J. GOULD, Professor of Psychology, Department of Psychology, Director of the Neuroscience Program, Temple University, Philadelphia, PA
CARL L. KEEN, Professor and Chair, Department of Nutrition, University of California, Davis
STEVEN E. LIPSHULTZ, Professor and Chairman of Pediatrics and Endowed Chair in Pediatric Cardiology, Children’s Hospital of the University of Miami, FL
THERESA ANN NICKLAS, Professor, Department of Pediatrics, Children’s Nutrition Research Center, Baylor College of Medicine, Houston, TX
BARBARA J. PETERSEN, Principal Scientist, Exponent, Inc., Washington, DC
JOSEPH V. RODRICKS, Principal, Environ International Corp., Arlington, VA
IOM Staff
ANN L. YAKTINE, Study Director
DIANA PANKEVICH, Senior Program Officer
JANET MULLIGAN, Research Associate
FAYE HILLMAN, Financial Associate
GERALDINE KENNEDO, Administrative Assistant
ANN L. YAKTINE, Interim Director, Food and Nutrition Board
ANDREW M. POPE, Director, Board on Health Sciences Policy
___________________
1Institute of Medicine planning committees are solely responsible for organizing the workshop, identifying topics, and choosing speakers. The responsibility for the published workshop summary rests with the workshop rapporteurs and the institution.
Reviewers
This workshop summary has been reviewed in draft form by individuals chosen for their diverse perspectives and technical expertise, in accordance with procedures approved by the National Research Council’s Report Review Committee. The purpose of this independent review is to provide candid and critical comments that will assist the institution in making its published workshop summary as sound as possible and to ensure that the workshop summary meets institutional standards for objectivity, evidence, and responsiveness to the study charge. The review comments and draft manuscript remain confidential to protect the integrity of the process. We wish to thank the following individuals for their review of this workshop summary:
ANNE BARNHILL, Perelman School of Medicine at the University of Pennsylvania
CINDY D. DAVIS, National Institutes of Health
JOHANNA T. DWYER, Tufts University Medical Center
CARL L. KEEN, University of California, Davis
NANCY S. WELLMAN, Florida International University
Although the reviewers listed above have provided many constructive comments and suggestions, they did not see the final draft of the workshop summary before its release. The review of this workshop summary was overseen by EILEEN T. KENNEDY, Tufts University. Appointed by the Institute of Medicine, she was responsible for making certain that an independent examination of this workshop summary was carried out in accordance with institutional procedures and that all review comments were carefully considered. Responsibility for the final
Contents
Background and Workshop Objectives
The Past, Present, and Future of Caffeine Regulation in the United States
2 INTAKE AND EXPOSURE TO CAFFEINE
Caffeine Intake from Beverages in the United States
Various Aspects of Caffeine Intake in America: Analysis of NHANES
Panelist Discussion with the Audience
3 SAFETY SIGNALS AND SURVEILLANCE
Caffeine and Energy Drink Exposure Call Surveillance
Safety Assessment of Caffeine in Foods and Beverages
Panelist Discussion with the Audience
4 EXPLORING SAFE CAFFEINE EXPOSURE LEVELS FOR VULNERABLE POPULATIONS
Safe Caffeine Exposure Levels in Vulnerable Populations: Pregnant Women and Infants
Risk of Adverse Effects of Caffeine and Caffeinated Products in Children and Other Vulnerable Groups
Panelist Discussion with the Audience
5 CAFFEINE EFFECTS ON THE CARDIOVASCULAR SYSTEM
Caffeine and Risk of Arrhythmia
Caffeine and Potential Risk of Hypertension
Panelist Discussion with the Audience
6 CAFFEINE EFFECTS ON THE CENTRAL NERVOUS SYSTEM AND BEHAVIORAL EFFECTS ASSOCIATED WITH CAFFEINE CONSUMPTION
Mechanisms of the Central Nervous System Effects of Caffeine
Developmental and Psychopharmacological Effects of Caffeine
Addictive Properties of Caffeine
DSM-5: Substance-Related and Addiction Disorders
Energy Drink Use and Risk Taking During Adolescence and Young Adulthood
Caffeine, Performance, and Well-Being
Panelist Discussion with the Audience
7 OTHER COMPOUNDS IMPACTING CAFFEINE EFFECTS
Interaction Between Energy Drink Ingredients and Caffeine
Panelist Discussion with the Audience
Richard H. Adamson, Ph.D., TPN Associates, LLC
John P. Higgins, M.D., M.B.A., University of Texas Medical School, Houston
Richard Kingston, Pharm.D., SafetyCall International, Bloomington, Minnesota
Emilia C. Lonardo, Ph.D., Grocery Manufacturers Association, Washington, DC
Rend Al-Mondhiry, J.D., Council for Responsible Nutrition, Washington, DC
John R. White, Jr., Pharm.D., Washington State University, Spokane
9 MOVING FORWARD: FILLING THE DATA GAPS
Panelist Discussion with the Audience
Boxes, Figures, and Tables
BOXES
FIGURES
|
Mean usual intake of caffeine for total sample population and caffeine consumers only |
|
|
Mean and percentiles of usual caffeine intake per consumption event |
|
|
Caffeine and energy product exposure calls per day over time |
|
|
Odds ratios of risk of myocardial infarction with coffee intake |
|
TABLES
|
ADHD |
attention deficit hyperactivity disorder |
|
CDC |
U.S. Centers for Disease Control and Prevention |
|
COMT |
catechol-O-methyltransferase |
|
CRN |
Council for Responsible Nutrition |
|
DAWN |
Drug Abuse Warning Network |
|
DSM |
Diagnostic and Statistical Manual |
|
ECF |
endothelial cell function |
|
EFSA |
European Food Safety Authority |
|
FDA |
U.S. Food and Drug Administration |
|
GABA |
gamma-aminobutyric acid |
|
GRAS |
generally recognized as safe |
|
ILSI |
International Life Sciences Institute |
|
IOM |
Institute of Medicine |
|
MSN |
medium spiny neuron |
|
NHANES |
National Health and Nutrition Examination Survey |
|
NOAEL |
no-observed-adverse-effect level |
|
NPDS |
National Poison Data System |
|
PVC |
premature ventricular complex |